| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.588 | 0.003 | 0.588 | HIV-1 reverse transcriptase inhibitor | 0.48 0.004 CID_10755325 0.454 0.004 CID_10978907 0.58 0.003 CID_10850461 0.483 0.004 CID_154700103 | ||
| 0.515 | 0.01 | 0.515 | RNA-directed DNA polymerase inhibitor | 0.495 0.011 CID_10755325 0.452 0.014 CID_10978907 0.473 0.012 CID_10850461 0.42 0.016 CID_154700103 | ||
| 0.524 | 0.024 | 0.524 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.363 0.136 CID_10755325 0.424 0.081 CID_10978907 0.479 0.044 CID_10850461 0.367 0.132 CID_154700103 | ||
| 0.382 | 0.026 | 0.481 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.346 0.038 CID_10755325 0.344 0.039 CID_10978907 0.324 0.049 CID_10850461 0.481 0.009 CID_154700103 | CID_154700103 | |
| 0.407 | 0.054 | 0.407 | MAP kinase kinase 6 inhibitor | 0.319 0.118 CID_10755325 0.325 0.113 CID_10978907 0.364 0.082 CID_10850461 0.256 0.182 CID_154700103 | ||
| 0.331 | 0.006 | 0.331 | DNA directed RNA polymerase inhibitor | 0.28 0.008 CID_10755325 0.242 0.009 CID_10978907 0.329 0.006 CID_10850461 0.248 0.009 CID_154700103 | ||
| 0.324 | 0.03 | 0.399 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.302 0.034 CID_10755325 0.256 0.043 CID_10978907 0.227 0.053 CID_10850461 0.399 0.018 CID_154700103 | CID_154700103 | |
| 0.301 | 0.039 | 0.318 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.318 0.033 CID_10755325 0.304 0.038 CID_10978907 0.265 0.053 CID_10850461 0.187 0.101 CID_154700103 | CID_10755325 | |
| 0.256 | 0.005 | 0.259 | Phosphodiesterase 4B inhibitor | 0.195 0.008 CID_10755325 0.071 0.043 CID_10978907 0.172 0.01 CID_10850461 0.259 0.005 CID_154700103 | CID_154700103 | |
| 0.282 | 0.035 | 0.285 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.24 0.079 CID_10755325 0.253 0.062 CID_10978907 0.285 0.033 CID_10850461 0.234 0.089 CID_154700103 | CID_10850461 | |
| 0.289 | 0.046 | 0.292 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.234 0.062 CID_10755325 0.206 0.072 CID_10978907 0.2 0.075 CID_10850461 0.292 0.045 CID_154700103 | CID_154700103 | |
| 0.249 | 0.022 | 0.322 | Phosphodiesterase inhibitor | 0.19 0.038 CID_10755325 0.224 0.028 CID_10978907 0.322 0.012 CID_10850461 0.19 0.038 CID_154700103 | CID_10850461 | |
| 0.244 | 0.022 | 0.301 | Ribosomal protein S6 kinase inhibitor | 0.222 0.029 CID_10755325 0.301 0.011 CID_10978907 0.144 0.069 CID_10850461 0.153 0.063 CID_154700103 | CID_10978907 | |
| 0.267 | 0.049 | 0.267 | MAP-kinase-activated kinase 5 inhibitor | 0.222 0.08 CID_10755325 0.219 0.083 CID_10978907 0.263 0.051 CID_10850461 0.186 0.122 CID_154700103 | ||
| 0.217 | 0.011 | 0.217 | Phosphodiesterase IV inhibitor | 0.181 0.016 CID_10755325 0.129 0.029 CID_10978907 0.174 0.017 CID_10850461 0.215 0.011 CID_154700103 | ||
| 0.215 | 0.011 | 0.215 | 5 Hydroxytryptamine 3A agonist | 0.16 0.03 CID_10755325 0.172 0.025 CID_10978907 0.139 0.042 CID_10850461 0.096 0.081 CID_154700103 | ||
| 0.236 | 0.035 | 0.271 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.183 0.051 CID_10755325 0.156 0.062 CID_10978907 0.147 0.066 CID_10850461 0.271 0.025 CID_154700103 | CID_154700103 | |
| 0.25 | 0.051 | 0.342 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.236 0.056 CID_10755325 0.216 0.066 CID_10978907 0.195 0.08 CID_10850461 0.342 0.025 CID_154700103 | CID_154700103 | |
| 0.239 | 0.043 | 0.239 | MAP kinase kinase 3 inhibitor | 0.196 0.133 CID_10755325 0.201 0.12 CID_10978907 0.212 0.09 CID_10850461 0.202 0.118 CID_154700103 | ||
| 0.219 | 0.027 | 0.219 | Glycogen synthase kinase-3 inhibitor | 0.155 0.044 CID_10755325 0.114 0.066 CID_10978907 0.192 0.033 CID_10850461 0.173 0.038 CID_154700103 | ||
| 0.215 | 0.025 | 0.215 | Glycogen synthase kinase-3 beta inhibitor | 0.155 0.041 CID_10755325 0.123 0.059 CID_10978907 0.182 0.033 CID_10850461 0.182 0.033 CID_154700103 | ||
| 0.237 | 0.053 | 0.242 | TRKC antagonist | 0.188 0.074 CID_10755325 0.159 0.094 CID_10978907 0.242 0.051 CID_10850461 | CID_10850461 | |
| 0.217 | 0.033 | 0.227 | Cyclin-dependent kinase inhibitor | 0.171 0.047 CID_10755325 0.156 0.054 CID_10978907 0.175 0.045 CID_10850461 0.227 0.031 CID_154700103 | CID_154700103 | |
| 0.211 | 0.032 | 0.211 | Activin receptor-like kinase 2 inhibitor | 0.209 0.033 CID_10755325 0.159 0.06 CID_10978907 0.148 0.069 CID_10850461 | ||
| 0.293 | 0.121 | 0.293 | Antiobesity | 0.251 0.156 CID_10755325 0.288 0.125 CID_154700103 | ||
| 0.174 | 0.009 | 0.174 | Cyclin-dependent kinase 4 inhibitor | 0.122 0.018 CID_10755325 0.126 0.017 CID_10978907 0.168 0.01 CID_10850461 0.172 0.009 CID_154700103 | ||
| 0.224 | 0.062 | 0.224 | Death-associated protein kinase 3 inhibitor | 0.204 0.072 CID_10755325 0.198 0.075 CID_10978907 0.162 0.106 CID_10850461 | ||
| 0.221 | 0.059 | 0.269 | Nitric-oxide synthase stimulant | 0.269 0.022 CID_10755325 0.219 0.062 CID_10978907 0.221 0.058 CID_10850461 0.192 0.102 CID_154700103 | CID_10755325 | |
| 0.173 | 0.017 | 0.173 | Death-associated protein kinase 1 inhibitor | 0.143 0.051 CID_10755325 0.15 0.04 CID_10978907 0.164 0.023 CID_10850461 0.141 0.056 CID_154700103 | ||
| 0.164 | 0.011 | 0.177 | Cyclin B3 inhibitor | 0.139 0.016 CID_10755325 0.141 0.015 CID_10978907 0.177 0.009 CID_10850461 0.131 0.018 CID_154700103 | CID_10850461 | |
| 0.285 | 0.132 | 0.38 | Histamine release inhibitor | 0.253 0.153 CID_10755325 0.299 0.124 CID_10978907 0.38 0.086 CID_154700103 | CID_154700103 | |
| 0.197 | 0.047 | 0.198 | Polo-like kinase-3 inhibitor | 0.166 0.068 CID_10755325 0.167 0.068 CID_10978907 0.198 0.046 CID_154700103 | CID_154700103 | |
| 0.186 | 0.047 | 0.186 | Death-associated protein kinase 2 inhibitor | 0.173 0.063 CID_10755325 0.183 0.05 CID_10978907 0.171 0.066 CID_10850461 0.139 0.134 CID_154700103 | ||
| 0.216 | 0.077 | 0.216 | EphB2 antagonist | 0.149 0.13 CID_10755325 0.153 0.127 CID_10978907 | ||
| 0.151 | 0.016 | 0.151 | Acetylcholine release stimulant | 0.105 0.077 CID_10850461 0.124 0.042 CID_154700103 | ||
| 0.138 | 0.008 | 0.138 | CDK4/cyclin D1 inhibitor | 0.104 0.014 CID_10755325 0.102 0.014 CID_10978907 0.105 0.013 CID_10850461 0.137 0.008 CID_154700103 | ||
| 0.221 | 0.093 | 0.257 | DNA synthesis inhibitor | 0.221 0.093 CID_10755325 0.257 0.062 CID_10978907 0.201 0.121 CID_10850461 0.213 0.103 CID_154700103 | CID_10978907 | |
| 0.14 | 0.012 | 0.14 | Bromodomain-containing protein 2 inhibitor | 0.091 0.053 CID_10755325 0.088 0.059 CID_10978907 0.117 0.025 CID_10850461 | ||
| 0.176 | 0.053 | 0.176 | Cyclin-dependent kinase 3 inhibitor | 0.152 0.092 CID_10755325 0.156 0.083 CID_10978907 0.149 0.097 CID_10850461 0.166 0.066 CID_154700103 | ||
| 0.264 | 0.142 | 0.264 | GABA C receptor rho-3 antagonist | 0.234 0.17 CID_10978907 | ||
| 0.184 | 0.071 | 0.203 | LIM domain kinase 1 inhibitor | 0.147 0.101 CID_10755325 0.203 0.061 CID_10850461 | CID_10850461 | |
| 0.125 | 0.014 | 0.125 | Benzodiazepine agonist | 0.072 0.048 CID_10850461 0.093 0.03 CID_154700103 | ||
| 0.141 | 0.033 | 0.141 | CDK/cyclin complex inhibitor | 0.09 0.059 CID_10755325 0.092 0.058 CID_10978907 0.102 0.051 CID_10850461 0.138 0.034 CID_154700103 | ||
| 0.118 | 0.011 | 0.122 | Polo-like kinase-2 inhibitor | 0.105 0.021 CID_10755325 0.108 0.019 CID_10978907 0.073 0.05 CID_10850461 0.122 0.009 CID_154700103 | CID_154700103 | |
| 0.116 | 0.01 | 0.116 | CDK4/cyclin D inhibitor | 0.086 0.019 CID_10755325 0.086 0.019 CID_10978907 0.097 0.015 CID_10850461 0.109 0.012 CID_154700103 | ||
| 0.192 | 0.087 | 0.192 | MAP kinase kinase 2 inhibitor | 0.161 0.111 CID_10755325 0.138 0.133 CID_10978907 0.166 0.107 CID_154700103 | ||
| 0.156 | 0.051 | 0.162 | MAP3K9 inhibitor | 0.145 0.068 CID_10755325 0.136 0.083 CID_10978907 0.162 0.044 CID_154700103 | CID_154700103 | |
| 0.144 | 0.039 | 0.144 | Polo-like kinase-4 inhibitor | 0.119 0.057 CID_10755325 0.105 0.071 CID_10978907 0.113 0.063 CID_10850461 | ||
| 0.117 | 0.013 | 0.135 | Phosphodiesterase VI inhibitor | 0.087 0.031 CID_10755325 0.074 0.053 CID_10978907 0.077 0.047 CID_10850461 0.135 0.009 CID_154700103 | CID_154700103 | |
| 0.176 | 0.072 | 0.176 | MAP kinase kinase 5 inhibitor | 0.154 0.138 CID_10755325 0.162 0.109 CID_10978907 0.165 0.1 CID_10850461 0.171 0.083 CID_154700103 | ||
| 0.298 | 0.196 | 0.339 | Caspase 9 stimulant | 0.26 0.241 CID_10755325 0.283 0.213 CID_10850461 0.339 0.154 CID_154700103 | CID_154700103 | |
| 0.111 | 0.011 | 0.111 | 5 Hydroxytryptamine 3 agonist | 0.062 0.046 CID_10755325 0.063 0.045 CID_10978907 0.063 0.043 CID_10850461 0.057 0.053 CID_154700103 | ||
| 0.139 | 0.039 | 0.139 | Protein kinase C gamma inhibitor | 0.132 0.043 CID_10755325 0.122 0.051 CID_10978907 0.108 0.064 CID_10850461 0.118 0.054 CID_154700103 | ||
| 0.154 | 0.065 | 0.154 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.134 0.106 CID_10755325 0.146 0.08 CID_10978907 0.139 0.094 CID_10850461 0.134 0.105 CID_154700103 | ||
| 0.098 | 0.011 | 0.099 | Cyclin-dependent kinase 6 inhibitor | 0.071 0.03 CID_10755325 0.075 0.026 CID_10978907 0.099 0.01 CID_10850461 0.076 0.025 CID_154700103 | CID_10850461 | |
| 0.178 | 0.091 | 0.178 | I kappa B kinase epsilon inhibitor | |||
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | 0.091 0.045 CID_10755325 0.098 0.035 CID_10978907 0.084 0.058 CID_10850461 0.086 0.054 CID_154700103 | ||
| 0.126 | 0.039 | 0.126 | Gastric antisecretory | 0.099 0.067 CID_10978907 0.106 0.058 CID_154700103 | ||
| 0.133 | 0.049 | 0.157 | Cyclin-dependent kinase 1 inhibitor | 0.11 0.06 CID_10755325 0.126 0.052 CID_10978907 0.108 0.061 CID_10850461 0.157 0.038 CID_154700103 | CID_154700103 | |
| 0.095 | 0.012 | 0.095 | Phosphodiesterase II inhibitor | 0.081 0.017 CID_10755325 0.073 0.021 CID_10978907 0.075 0.02 CID_10850461 0.073 0.021 CID_154700103 | ||
| 0.148 | 0.065 | 0.148 | Tyrosine-protein kinase receptor antagonist | 0.127 0.08 CID_10850461 | ||
| 0.175 | 0.093 | 0.175 | Focal adhesion kinase 2 inhibitor | |||
| 0.115 | 0.033 | 0.115 | Polo-like kinase-1 inhibitor | 0.084 0.075 CID_10978907 0.109 0.037 CID_154700103 | ||
| 0.096 | 0.016 | 0.096 | Protein kinase C beta inhibitor | 0.076 0.036 CID_10755325 0.075 0.039 CID_10978907 0.081 0.029 CID_10850461 0.077 0.035 CID_154700103 | ||
| 0.183 | 0.108 | 0.183 | Cyclic AMP phosphodiesterase inhibitor | 0.152 0.149 CID_10755325 0.154 0.146 CID_10850461 0.174 0.117 CID_154700103 | ||
| 0.118 | 0.043 | 0.118 | Insulin receptor antagonist | |||
| 0.101 | 0.027 | 0.101 | Caspase 7 inhibitor | 0.078 0.067 CID_10755325 0.078 0.067 CID_10978907 | ||
| 0.108 | 0.035 | 0.121 | Phosphodiesterase I inhibitor | 0.081 0.074 CID_10755325 0.081 0.074 CID_10978907 0.121 0.027 CID_10850461 0.08 0.077 CID_154700103 | CID_10850461 | |
| 0.093 | 0.02 | 0.093 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.084 | 0.012 | 0.084 | Phosphodiesterase 2A inhibitor | 0.071 0.017 CID_10755325 0.065 0.021 CID_10978907 0.065 0.021 CID_10850461 0.064 0.021 CID_154700103 | ||
| 0.125 | 0.055 | 0.148 | Cyclin-dependent kinase 5 inhibitor | 0.148 0.042 CID_10755325 0.104 0.072 CID_10978907 0.105 0.071 CID_154700103 | CID_10755325 | |
| 0.105 | 0.035 | 0.105 | MAP-kinase-activated kinase inhibitor | 0.099 0.04 CID_10755325 0.084 0.056 CID_10978907 0.078 0.065 CID_10850461 0.081 0.061 CID_154700103 | ||
| 0.148 | 0.081 | 0.148 | Cyclin-dependent kinase 8 inhibitor | 0.145 0.084 CID_10755325 | ||
| 0.139 | 0.072 | 0.139 | Cytokine production inhibitor | |||
| 0.113 | 0.046 | 0.113 | Folate antagonist | 0.104 0.058 CID_10755325 0.094 0.077 CID_10978907 0.101 0.063 CID_10850461 0.103 0.059 CID_154700103 | ||
| 0.131 | 0.064 | 0.163 | Glutamate receptor antagonist | 0.163 0.042 CID_10755325 0.133 0.063 CID_10850461 0.131 0.065 CID_154700103 | CID_10755325 | |
| 0.108 | 0.042 | 0.125 | Protein kinase C zeta inhibitor | 0.125 0.029 CID_10755325 0.111 0.039 CID_10978907 0.084 0.076 CID_154700103 | CID_10755325 | |
| 0.127 | 0.062 | 0.127 | TRKA antagonist | 0.11 0.077 CID_10850461 | ||
| 0.116 | 0.052 | 0.116 | Interleukin 2 antagonist | |||
| 0.109 | 0.045 | 0.109 | Protein kinase C delta inhibitor | 0.092 0.061 CID_10755325 0.084 0.07 CID_10978907 0.081 0.075 CID_10850461 0.082 0.073 CID_154700103 | ||
| 0.111 | 0.048 | 0.111 | Protein kinase C mu inhibitor | 0.089 0.069 CID_10755325 0.097 0.06 CID_10978907 0.104 0.053 CID_10850461 | ||
| 0.143 | 0.081 | 0.15 | Acetylcholine M1 receptor antagonist | 0.149 0.076 CID_10850461 0.15 0.074 CID_154700103 | CID_154700103 | |
| 0.119 | 0.057 | 0.119 | Sphingosine 1-phosphate receptor 2 agonist | 0.106 0.086 CID_10850461 0.102 0.095 CID_154700103 | ||
| 0.089 | 0.028 | 0.089 | Protein kinase C alpha inhibitor | 0.061 0.059 CID_10755325 0.064 0.052 CID_10850461 0.089 0.028 CID_154700103 | ||
| 0.128 | 0.067 | 0.134 | Protein kinase (CK1) delta inhibitor | 0.134 0.063 CID_10755325 | CID_10755325 | |
| 0.069 | 0.01 | 0.069 | Benzodiazepine inverse agonist | 0.052 0.022 CID_10755325 0.056 0.018 CID_10978907 0.062 0.013 CID_10850461 0.057 0.017 CID_154700103 | ||
| 0.107 | 0.048 | 0.107 | Electrolyte absorption antagonist | 0.106 0.05 CID_10850461 | ||
| 0.077 | 0.02 | 0.077 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.091 | 0.034 | 0.091 | MAP-kinase-activated kinase 2 inhibitor | 0.086 0.039 CID_10755325 0.072 0.054 CID_10978907 0.066 0.065 CID_10850461 0.07 0.058 CID_154700103 | ||
| 0.07 | 0.013 | 0.484 | Nicotinic acid receptor 1 agonist | 0.077 0.011 CID_10755325 0.038 0.032 CID_10978907 0.484 0.001 CID_10850461 0.044 0.024 CID_154700103 | CID_10850461 | |
| 0.102 | 0.048 | 0.106 | Phosphodiesterase 6D inhibitor | 0.106 0.041 CID_154700103 | CID_154700103 | |
| 0.077 | 0.024 | 0.084 | Cyclin B1 inhibitor | 0.063 0.04 CID_10755325 0.067 0.035 CID_10978907 0.084 0.018 CID_10850461 0.074 0.028 CID_154700103 | CID_10850461 | |
| 0.099 | 0.046 | 0.103 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.103 0.043 CID_10755325 0.088 0.06 CID_154700103 | CID_10755325 | |
| 0.076 | 0.025 | 0.076 | Protein kinase C eta inhibitor | 0.066 0.031 CID_10755325 0.051 0.042 CID_10978907 0.056 0.037 CID_10850461 | ||
| 0.071 | 0.02 | 0.079 | Cyclin B2 inhibitor | 0.059 0.033 CID_10755325 0.063 0.028 CID_10978907 0.079 0.015 CID_10850461 0.069 0.023 CID_154700103 | CID_10850461 | |
| 0.071 | 0.02 | 0.078 | AMPA receptor antagonist | 0.053 0.029 CID_10755325 0.078 0.018 CID_10850461 0.064 0.023 CID_154700103 | CID_10850461 | |
| 0.072 | 0.022 | 0.072 | Phosphodiesterase 1A inhibitor | 0.059 0.044 CID_10978907 0.072 0.022 CID_10850461 | ||
| 0.163 | 0.115 | 0.163 | Growth factor agonist | |||
| 0.097 | 0.049 | 0.097 | Insulin growth factor antagonist | |||
| 0.093 | 0.047 | 0.093 | Insulin like growth factor 1 antagonist | |||
| 0.111 | 0.065 | 0.111 | GABA receptor agonist | 0.099 0.078 CID_154700103 | ||
| 0.143 | 0.1 | 0.143 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.127 0.118 CID_10755325 | ||
| 0.128 | 0.085 | 0.128 | Protein kinase (CK1) inhibitor | 0.117 0.094 CID_10755325 | ||
| 0.071 | 0.029 | 0.071 | Glutamate (mGluR1) antagonist | 0.053 0.045 CID_10850461 | ||
| 0.08 | 0.039 | 0.08 | CDK1/cyclin B1 inhibitor | 0.068 0.05 CID_10755325 0.073 0.045 CID_10978907 0.073 0.044 CID_154700103 | ||
| 0.1 | 0.061 | 0.1 | mTOR complex 1 inhibitor | 0.1 0.062 CID_10850461 | ||
| 0.052 | 0.014 | 0.11 | Nicotinic acid receptor agonist | 0.104 0.005 CID_10755325 0.042 0.019 CID_10978907 0.11 0.004 CID_10850461 0.069 0.009 CID_154700103 | CID_10850461 | |
| 0.067 | 0.029 | 0.067 | Phosphodiesterase 4C inhibitor | |||
| 0.135 | 0.097 | 0.152 | MAP kinase kinase 4 inhibitor | 0.141 0.082 CID_10755325 0.135 0.1 CID_10978907 0.152 0.058 CID_154700103 | CID_154700103 | |
| 0.071 | 0.034 | 0.086 | Phosphodiesterase VII inhibitor | 0.086 0.021 CID_10850461 | CID_10850461 | |
| 0.055 | 0.017 | 0.055 | Glutamate (mGluR4) antagonist | 0.054 0.018 CID_154700103 | ||
| 0.101 | 0.063 | 0.231 | Bronchodilator | 0.098 0.066 CID_10755325 0.231 0.014 CID_10978907 0.105 0.058 CID_10850461 0.128 0.04 CID_154700103 | CID_10978907 | |
| 0.121 | 0.084 | 0.121 | Glycogen synthase kinase-3 alpha inhibitor | 0.109 0.094 CID_154700103 | ||
| 0.124 | 0.088 | 0.124 | Protein kinase C nu inhibitor | 0.118 0.095 CID_10755325 0.109 0.107 CID_10978907 | ||
| 0.063 | 0.028 | 0.07 | Cyclin B inhibitor | 0.051 0.044 CID_10755325 0.055 0.038 CID_10978907 0.07 0.022 CID_10850461 0.06 0.032 CID_154700103 | CID_10850461 | |
| 0.081 | 0.046 | 0.081 | Acetylcholine M4 receptor antagonist | |||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | 0.076 0.072 CID_154700103 | ||
| 0.043 | 0.01 | 0.043 | CDK6/cyclin D3 inhibitor | 0.036 0.019 CID_10755325 0.036 0.018 CID_10978907 0.041 0.012 CID_10850461 0.036 0.02 CID_154700103 | ||
| 0.125 | 0.093 | 0.125 | Aurora-C kinase inhibitor | |||
| 0.049 | 0.018 | 0.05 | DNA gyrase subunit A inhibitor | 0.049 0.019 CID_10755325 0.05 0.017 CID_10978907 0.047 0.02 CID_10850461 0.042 0.03 CID_154700103 | CID_10978907 | |
| 0.046 | 0.016 | 0.046 | 5 Hydroxytryptamine 2B agonist | |||
| 0.046 | 0.017 | 0.05 | MAP3K5 inhibitor | 0.05 0.013 CID_10850461 | CID_10850461 | |
| 0.042 | 0.013 | 0.055 | Calcitonin gene-related peptide antagonist | 0.055 0.009 CID_10850461 | CID_10850461 | |
| 0.083 | 0.054 | 0.091 | Phosphodiesterase XI inhibitor | 0.077 0.066 CID_10850461 0.091 0.041 CID_154700103 | CID_154700103 | |
| 0.083 | 0.054 | 0.091 | Phosphodiesterase 11A inhibitor | 0.077 0.066 CID_10850461 0.091 0.041 CID_154700103 | CID_154700103 | |
| 0.038 | 0.01 | 0.038 | DNA topoisomerase IV inhibitor | 0.031 0.018 CID_10755325 0.031 0.018 CID_10978907 0.038 0.009 CID_10850461 0.033 0.014 CID_154700103 | ||
| 0.113 | 0.088 | 0.113 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.106 0.095 CID_10755325 | ||
| 0.075 | 0.049 | 0.075 | Protein kinase B beta inhibitor | 0.07 0.057 CID_10755325 | ||
| 0.033 | 0.007 | 0.04 | Phosphodiesterase IX inhibitor | 0.025 0.014 CID_10755325 0.023 0.016 CID_10978907 0.04 0.005 CID_10850461 0.022 0.018 CID_154700103 | CID_10850461 | |
| 0.049 | 0.024 | 0.093 | Poly(ADP-ribose) polymerase inhibitor | 0.093 0.009 CID_10850461 | CID_10850461 | |
| 0.032 | 0.008 | 0.038 | Phosphodiesterase 9A inhibitor | 0.026 0.015 CID_10755325 0.024 0.017 CID_10978907 0.038 0.005 CID_10850461 0.023 0.019 CID_154700103 | CID_10850461 | |
| 0.037 | 0.014 | 0.037 | Protein kinase C beta I inhibitor | 0.035 0.019 CID_10755325 0.033 0.025 CID_10978907 0.035 0.018 CID_10850461 0.032 0.029 CID_154700103 | ||
| 0.046 | 0.024 | 0.049 | CDK5/p25 inhibitor | 0.049 0.022 CID_10850461 | CID_10850461 | |
| 0.072 | 0.049 | 0.072 | Orexin receptor 1 antagonist | |||
| 0.036 | 0.014 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.028 0.024 CID_10850461 | ||
| 0.074 | 0.052 | 0.074 | Rho-associated kinase I inhibitor | |||
| 0.063 | 0.042 | 0.063 | Phosphodiesterase 1C inhibitor | 0.058 0.054 CID_10978907 | ||
| 0.037 | 0.016 | 0.037 | Acetylcholine M4 receptor agonist | |||
| 0.081 | 0.061 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 CID_10850461 | CID_10850461 | |
| 0.04 | 0.021 | 0.04 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.053 | 0.034 | 0.062 | Phosphodiesterase 7A inhibitor | 0.062 0.02 CID_10850461 | CID_10850461 | |
| 0.056 | 0.037 | 0.058 | Bromodomain-containing protein 4 inhibitor | 0.058 0.034 CID_10850461 | CID_10850461 | |
| 0.048 | 0.029 | 0.048 | Glutamate (mGluR5) agonist | |||
| 0.065 | 0.049 | 0.075 | CDC7 inhibitor | 0.075 0.039 CID_10850461 | CID_10850461 | |
| 0.094 | 0.078 | 0.094 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.059 | 0.043 | 0.064 | CDK2/cyclin E inhibitor | 0.064 0.039 CID_154700103 | CID_154700103 | |
| 0.056 | 0.04 | 0.056 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.091 | 0.075 | 0.091 | MAP kinase kinase kinase inhibitor | |||
| 0.061 | 0.046 | 0.068 | CDK1/cyclin B inhibitor | 0.068 0.04 CID_154700103 | CID_154700103 | |
| 0.247 | 0.232 | 0.297 | 5 Hydroxytryptamine release inhibitor | 0.297 0.168 CID_154700103 | CID_154700103 | |
| 0.044 | 0.03 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.055 | 0.042 | 0.071 | Fatty acid synthase inhibitor | 0.071 0.025 CID_10755325 0.053 0.045 CID_10978907 | CID_10755325 | |
| 0.017 | 0.004 | 0.017 | Cyclin D2 inhibitor | 0.013 0.011 CID_10978907 0.017 0.004 CID_10850461 0.013 0.009 CID_154700103 | ||
| 0.057 | 0.045 | 0.06 | Cyclin A1 inhibitor | 0.06 0.039 CID_10850461 | CID_10850461 | |
| 0.092 | 0.08 | 0.105 | Cyclin-dependent kinase 2 inhibitor | 0.105 0.064 CID_154700103 | CID_154700103 | |
| 0.033 | 0.021 | 0.033 | Protein kinase C beta II inhibitor | 0.031 0.027 CID_10978907 0.033 0.02 CID_154700103 | ||
| 0.104 | 0.092 | 0.104 | MAP kinase 12 inhibitor | |||
| 0.076 | 0.064 | 0.076 | Acetylcholine M3 receptor agonist | 0.071 0.07 CID_10850461 | ||
| 0.109 | 0.1 | 0.109 | DNA repair enzyme inhibitor | |||
| 0.047 | 0.039 | 0.047 | Bromodomain-containing protein 3 inhibitor | |||
| 0.031 | 0.023 | 0.032 | HCV NS5B polymerase inhibitor | 0.032 0.021 CID_10978907 | CID_10978907 | |
| 0.075 | 0.067 | 0.075 | MAP kinase 7 inhibitor | |||
| 0.033 | 0.025 | 0.033 | RNA-directed RNA polymerase inhibitor | 0.031 0.03 CID_10755325 0.032 0.028 CID_10978907 | ||
| 0.055 | 0.049 | 0.055 | Phosphodiesterase 1B inhibitor | 0.055 0.05 CID_10850461 | ||
| 0.036 | 0.029 | 0.075 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.075 0.01 CID_10850461 | CID_10850461 | |
| 0.073 | 0.067 | 0.098 | Protein kinase A inhibitor | 0.098 0.046 CID_10755325 0.084 0.057 CID_154700103 | CID_10755325 | |
| 0.125 | 0.119 | 0.125 | MAP kinase 3 inhibitor | |||
| 0.044 | 0.038 | 0.044 | Glutamate (mGluR group I) agonist | |||
| 0.186 | 0.181 | 0.229 | Immunomodulator | 0.229 0.133 CID_154700103 | CID_154700103 | |
| 0.064 | 0.059 | 0.153 | Phosphodiesterase V inhibitor | 0.153 0.01 CID_10850461 0.1 0.028 CID_154700103 | CID_10850461 | |
| 0.055 | 0.051 | 0.082 | Cyclin D1 inhibitor | 0.082 0.016 CID_154700103 | CID_154700103 | |
| 0.035 | 0.031 | 0.039 | Cyclin D3 inhibitor | 0.039 0.028 CID_10850461 | CID_10850461 | |
| 0.043 | 0.04 | 0.049 | Phosphodiesterase 4A inhibitor | 0.049 0.036 CID_10978907 | CID_10978907 | |
| 0.016 | 0.013 | 0.018 | Calcitonin gene-related peptide 1 receptor antagonist | 0.018 0.01 CID_10850461 | CID_10850461 | |
| 0.061 | 0.061 | 0.151 | Phosphodiesterase 5A inhibitor | 0.151 0.01 CID_10850461 0.098 0.027 CID_154700103 | CID_10850461 | |
| 0.055 | 0.056 | 0.07 | DNA gyrase inhibitor | 0.07 0.036 CID_10850461 0.07 0.036 CID_154700103 | CID_154700103 | |
| 0.118 | 0.12 | 0.178 | CDC-like kinase 2 inhibitor | 0.178 0.078 CID_10755325 | CID_10755325 | |
| 0.023 | 0.026 | 0.029 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.029 0.019 CID_10850461 | CID_10850461 | |
| 0.12 | 0.128 | 0.141 | CDC-like kinase 4 inhibitor | 0.141 0.109 CID_10755325 | CID_10755325 | |
| 0.061 | 0.073 | 0.075 | MDM2 inhibitor | 0.075 0.027 CID_154700103 | CID_154700103 | |
| 0.045 | 0.059 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.053 0.044 CID_154700103 | CID_154700103 | |
| 0.033 | 0.048 | 0.037 | Thymidine kinase inhibitor | 0.037 0.036 CID_154700103 | CID_154700103 | |
| 0.019 | 0.033 | 0.035 | Cyclin E2 inhibitor | 0.035 0.015 CID_154700103 | CID_154700103 | |
| 0.181 | 0.198 | 0.251 | Vasodilator, peripheral | 0.251 0.126 CID_154700103 | CID_154700103 | |
| 0.054 | 0.074 | 0.063 | CDK2/cyclin E2 inhibitor | 0.063 0.058 CID_154700103 | CID_154700103 | |
| 0.052 | 0.081 | 0.089 | Protein kinase B alpha inhibitor | 0.069 0.048 CID_10755325 0.089 0.036 CID_10978907 | CID_10978907 | |
| 0.043 | 0.077 | 0.095 | Phosphodiesterase III inhibitor | 0.095 0.025 CID_10850461 | CID_10850461 | |
| 0.017 | 0.053 | 0.023 | Phosphodiesterase 6A inhibitor | 0.023 0.017 CID_154700103 | CID_154700103 | |
| 0.114 | 0.152 | 0.149 | Clk dual-specificity kinase inhibitor | 0.149 0.115 CID_10755325 0.134 0.13 CID_10850461 | CID_10755325 | |
| 0.026 | 0.07 | 0.051 | Cyclin E1 inhibitor | 0.051 0.037 CID_154700103 | CID_154700103 | |
| 0.065 | 0.11 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.059 CID_10755325 0.075 0.063 CID_154700103 | CID_10755325 | |
| 0.025 | 0.071 | 0.048 | Phosphodiesterase 3B inhibitor | 0.048 0.027 CID_10850461 | CID_10850461 | |
| 0.029 | 0.078 | 0.057 | Cyclin E inhibitor | 0.057 0.043 CID_154700103 | CID_154700103 | |
| 0.088 | 0.136 | 0.132 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.131 0.092 CID_10755325 0.132 0.09 CID_10978907 | CID_10978907 | |
| 0.111 | 0.161 | 0.147 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.147 0.123 CID_10755325 | CID_10755325 | |
| 0.054 | 0.109 | 0.095 | Phosphodiesterase 3A inhibitor | 0.095 0.036 CID_10850461 | CID_10850461 | |
| 0.128 | 0.19 | 0.275 | Tumour necrosis factor alpha release inhibitor | 0.275 0.064 CID_10978907 | CID_10978907 | |
| 0.059 | 0.124 | 0.094 | Mediator release inhibitor | 0.094 0.077 CID_154700103 | CID_154700103 | |
| 0.033 | 0.1 | 0.05 | Nicotinic receptor alpha4 subunit antagonist | 0.05 0.032 CID_10755325 | CID_10755325 | |
| 0.069 | 0.149 | 0.116 | MAP kinase kinase inhibitor | 0.116 0.078 CID_10978907 | CID_10978907 | |
| 0.014 | 0.1 | 0.09 | Nicotinic acid receptor 2 agonist | 0.09 0.006 CID_10755325 | CID_10755325 | |
| 0.087 | 0.173 | 0.139 | Diuretic | 0.139 0.087 CID_154700103 | CID_154700103 | |
| 0.064 | 0.153 | 0.089 | MAP kinase kinase 1 inhibitor | 0.089 0.072 CID_10978907 | CID_10978907 | |
| 0.078 | 0.177 | 0.126 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.126 0.1 CID_10755325 | CID_10755325 | |
| 0.16 | 0.26 | 0.375 | Toll-Like receptor agonist | 0.375 0.07 CID_10978907 0.25 0.149 CID_154700103 | CID_10978907 | |
| 0.1 | 0.201 | 0.168 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.168 0.116 CID_10755325 | CID_10755325 | |
| 0.11 | 0.213 | 0.16 | Neurotrophic factor enhancer | 0.16 0.124 CID_10978907 | CID_10978907 | |
| 0.158 | 0.264 | 0.372 | Toll-Like receptor 7 agonist | 0.372 0.071 CID_10978907 0.24 0.156 CID_154700103 | CID_10978907 | |
| 0.099 | 0.21 | 0.162 | Dyrk kinase inhibitor | 0.162 0.125 CID_10755325 | CID_10755325 | |
| 0.009 | 0.128 | 0.028 | Progesterone receptor B antagonist | 0.028 0.005 CID_10850461 | CID_10850461 | |
| 0.18 | 0.306 | 0.349 | Cyclophilin D inhibitor | 0.247 0.217 CID_10755325 0.349 0.123 CID_154700103 | CID_154700103 | |
| 0.046 | 0.172 | 0.111 | Hepatocyte growth factor antagonist | 0.111 0.042 CID_10978907 | CID_10978907 | |
| 0.153 | 0.289 | 0.202 | Interleukin 2 agonist | 0.202 0.186 CID_154700103 | CID_154700103 | |
| 0.045 | 0.191 | 0.108 | Creatine kinase inhibitor | 0.108 0.052 CID_10755325 | CID_10755325 | |
| 0.172 | 0.33 | 0.231 | Calcium channel L-type activator | 0.231 0.228 CID_10978907 | CID_10978907 | |
| 0.032 | 0.194 | 0.078 | Fibroblast growth factor 1 antagonist | 0.078 0.076 CID_10978907 | CID_10978907 | |
| 0.12 | 0.288 | 0.236 | Angiogenesis inhibitor | 0.236 0.133 CID_10978907 | CID_10978907 | |
| 0.027 | 0.196 | 0.074 | Transcription factor AP-1 inhibitor | 0.074 0.027 CID_10850461 | CID_10850461 | |
| 0.122 | 0.351 | 0.199 | Apoptosis antagonist | 0.199 0.18 CID_154700103 | CID_154700103 | |
| 0.042 | 0.304 | 0.139 | Neurotrophic factor | 0.139 0.07 CID_154700103 | CID_154700103 | |
| 0.111 | 0.499 | 0.335 | Antiinflammatory | 0.263 0.253 CID_10755325 0.335 0.184 CID_10978907 | CID_10978907 | |
| 0.021 | 0.473 | 0.087 | Uric acid excretion stimulant | 0.087 0.069 CID_10978907 | CID_10978907 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |